Arthur L. Burnett, II, MD, MBA
Multiple factors may contribute to care inequity
"As much as racial and ethnic disparities exist broadly across health care in the United States, it is not surprising to observe this phenomenon in the urologic arena," writes Arthur L. Burnett, II, MD, MBA.
Study offers practical insights on TRT use
Although a recent study of testosterone therapy does not fulfill the need for large-scale, randomized, controlled studies of the treatment, “it is very informative in several ways,” writes Arthur L. Burnett, II, MD, MBA.
Study questions use of pre-op cultures to prevent prosthetic infection
In this video, Dr. Nicholas Kavoussi sits down with Dr. Arthur L. Burnett, II, of the Urology Times Editorial Council to discuss his 2016 AUA presentation, "Preoperative urine cultures for prosthetic urological surgery: What is the evidence?"
A curative therapy for ED edges forward
Shock wave therapy has now been subjected to multiple randomized, placebo-controlled, and additional open-label studies in clinics worldwide, demonstrating impressive efficacy and safety.